» start page

 » WebMicroscope
     tutorial / help

 » Gleason grading
     background
    
tutorials

 » documentation
   
publications
   
supplemental info

 » about us / contact

 » start / end grading

 » interactive grading
    with instant feedback

 » interobserver varia-
    bility assessment

 » intraobserver
    agreement
 » save / load


Click to open
schematic reference
image

Background
The Gleason grading system is the most widely used
and accepted grading system for prostatic adenocar-
cinoma. The Gleason grade of a prostate needle
biopsy can have important clinical implications, and
to ensure objective therapeutic decisions, grading
should be as accurate and uniform as possible.

The Gleason grading system is based on evalua-
ting the architectural pattern of the malignant glands
observed at a relatively low magnification. The two
most prevalent patterns are assigned grades from 1
to 5, with 1 being the most differentiated and 5 the least
differentiated. The sum of the two grades, called the
Gleason score, thus obtains values from 2 to 10.



Schematic Gleason diagram
appearing at the site by
Lars Egevad, Karolinska Hospital

Schematic diagram of the Gleason grading system (opens in new window)

Links to useful resources and tutorials

Reference images by Lars Egevad, Department of Pathology and Cytology,
Karolinska Hospital, Stockholm.


Gleason grading of prostate cancer, 13 practical clues by David G. Bostwick
at the Bostwick Laboratories, Richmond, USA


Gleason Grading of Prostatic Carcinoma - classical Gleason patterns and
problem areas. Departments of Pathology, The Johns Hopkins Hospital, Baltimore


Gleason's Grading of Prostate Needle Biopsies. A tutorial and testing web site
at Departments of Pathology, The Johns Hopkins Hospital, Baltimore


The 2005 International Society of Urological Pathology (ISUP) Consensus
Conference on Gleason Grading of Prostatic Carcinoma.


The grading system was presented by Dr Gleason in 1974 in
the journal article:

  
  
Prediction of prognosis for prostatic adenocarcinoma by combined histological
   grading and clinical staging. J Urol. 1974 Jan;111(1):58-64. (No abstract available)